JP2006512335A5 - - Google Patents

Download PDF

Info

Publication number
JP2006512335A5
JP2006512335A5 JP2004558137A JP2004558137A JP2006512335A5 JP 2006512335 A5 JP2006512335 A5 JP 2006512335A5 JP 2004558137 A JP2004558137 A JP 2004558137A JP 2004558137 A JP2004558137 A JP 2004558137A JP 2006512335 A5 JP2006512335 A5 JP 2006512335A5
Authority
JP
Japan
Prior art keywords
group
carbon atoms
protected
coor
cooh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004558137A
Other languages
English (en)
Japanese (ja)
Other versions
JP4954477B2 (ja
JP2006512335A (ja
Filing date
Publication date
Priority claimed from FR0215428A external-priority patent/FR2848210B1/fr
Application filed filed Critical
Publication of JP2006512335A publication Critical patent/JP2006512335A/ja
Publication of JP2006512335A5 publication Critical patent/JP2006512335A5/ja
Application granted granted Critical
Publication of JP4954477B2 publication Critical patent/JP4954477B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004558137A 2002-12-06 2003-11-28 新規複素環化合物、それらの調製、ならびに薬剤として、特に抗菌剤およびβ−ラクタマーゼ阻害剤としてのそれらの使用 Expired - Fee Related JP4954477B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR02/15428 2002-12-06
FR0215428A FR2848210B1 (fr) 2002-12-06 2002-12-06 Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases
PCT/FR2003/003523 WO2004052891A1 (fr) 2002-12-06 2003-11-28 Composes heterocyclique, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens et inhibiteurs de beta-lactamases

Publications (3)

Publication Number Publication Date
JP2006512335A JP2006512335A (ja) 2006-04-13
JP2006512335A5 true JP2006512335A5 (https=) 2012-03-22
JP4954477B2 JP4954477B2 (ja) 2012-06-13

Family

ID=32320045

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004558137A Expired - Fee Related JP4954477B2 (ja) 2002-12-06 2003-11-28 新規複素環化合物、それらの調製、ならびに薬剤として、特に抗菌剤およびβ−ラクタマーゼ阻害剤としてのそれらの使用

Country Status (9)

Country Link
EP (1) EP1569935B1 (https=)
JP (1) JP4954477B2 (https=)
KR (1) KR101146802B1 (https=)
AT (1) ATE405567T1 (https=)
AU (1) AU2003294104A1 (https=)
CA (1) CA2507607C (https=)
DE (1) DE60323135D1 (https=)
FR (1) FR2848210B1 (https=)
WO (1) WO2004052891A1 (https=)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2844273B1 (fr) 2002-09-05 2008-04-04 Aventis Pharma Sa Nouveaux composes heterocycliques, procede et intermediaires de preparation et utilisation comme medicament, notamment comme inhibiteurs de beta-lactamases et anti-bacteriens.
KR101594898B1 (ko) 2005-07-15 2016-02-18 알바니 몰레큘라 리써치, 인크. 아릴- 및 헤테로아릴-치환된 테트라히드로벤자제핀, 및 노르에피네프린, 도파민 및 세로토닌의 재흡수를 차단하기 위한 용도
CA2783572C (en) 2005-12-07 2016-08-09 Basilea Pharmaceutica Ag Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
FR2914923B1 (fr) * 2007-04-12 2013-06-14 Novexel Nouveaux composes heterocycliques azotes,leur preparation et leur utilisation comme medicaments antibacteriens.
FR2921060B1 (fr) * 2007-09-14 2012-06-15 Novexel Nouveau procede de preparation d'une piperidine disubsituee et nouveaux intermediaires
FR2936798B1 (fr) * 2008-10-03 2012-09-28 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens.
FR2937034B1 (fr) 2008-10-10 2012-11-23 Novexel Nouveaux composes heterocycliques azotes, leur preparation et leur utilisation comme medicaments antibacteriens
FR2936951B1 (fr) * 2008-10-10 2010-12-03 Novexel Nouvelles combinaisons de composes heterocycliques azotes antibacteriens avec d'autres composes antibacteriens et leur utilisation comme medicaments
US8796257B2 (en) 2011-12-02 2014-08-05 Naeja Pharmaceutical Inc. Bicyclic compounds and their use as antibacterial agents and β-lactamase inhibitors
US9505761B2 (en) 2011-12-02 2016-11-29 Fedora Pharmaceuticals Inc. Bicyclic compounds and their use as antibacterial agents and beta-lactamase inhibitors
BR112015003592B1 (pt) * 2012-08-25 2020-04-14 Wockhardt Ltd derivados de 1,6-diazabiciclo[3,2,1]octan-7-ona e seu uso no tratamento de infecções bacterianas
UA111925C2 (uk) 2012-12-11 2016-06-24 Федора Фармасьютікалз Інк. БІЦИКЛІЧНІ СПОЛУКИ ТА ЇХ ВИКОРИСТАННЯ ЯК АНТИБАКТЕРІАЛЬНИХ АГЕНТІВ ТА ІНГІБІТОРІВ β-ЛАКТАМАЗИ
WO2014141132A1 (en) * 2013-03-14 2014-09-18 Naeja Pharmaceutical Inc. NEW HETEROCYCLIC COMPOUNDS AND THEIR USE AS ANTIBACTERIAL AGENTS AND β-LACTAMASE INHIBITORS
KR102542392B1 (ko) * 2014-11-17 2023-06-09 엔타시스 테라퓨틱스 리미티드 내성 박테리아 감염의 치료를 위한 배합물 치료제
CN114591223B (zh) 2016-09-16 2025-01-24 恩塔西斯治疗有限公司 β-内酰胺酶抑制剂化合物
JOP20190061A1 (ar) 2016-09-28 2019-03-26 Novartis Ag مثبطات بيتا-لاكتاماز
NZ758200A (en) 2017-05-08 2025-12-19 Entasis Therapeutics Inc Compounds and methods for treating bacterial infections
EP3604309A1 (en) 2018-07-30 2020-02-05 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
EP3604315A1 (en) * 2018-07-30 2020-02-05 Mutabilis Heterocyclic compounds and their use in preventing or treating bacterial infections
EP4146650B1 (en) 2020-09-01 2026-01-21 Ningxia Academy of Agriculture and Forestry Sciences Beta-lactamase inhibitors and their preparation
US12410166B2 (en) 2021-05-07 2025-09-09 Ningxia Academy Of Agriculture And Forestry Sciences Sulfonylamidine substituted compounds and their use as beta-lactamase inhibitors
WO2024227071A1 (en) * 2023-04-26 2024-10-31 Entasis Therapeutics Limited Synthesis of durlobactam

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2676230B1 (fr) * 1991-05-07 1993-08-27 Centre Nat Rech Scient Nouveaux derives de pyrrolo [1,4]-benzodiazepines, leur procede de preparation et medicaments les contenant.
HUT74682A (en) * 1993-12-29 1997-01-28 Pfizer Diazabicyclic neurokinin antagonists and pharmaceutical compositions containing them
DE19627431A1 (de) * 1996-07-08 1998-01-15 Bayer Ag Heterocyclisch kondensierte Pyridine
AU4698399A (en) * 1998-06-30 2000-01-17 Du Pont Pharmaceuticals Company 1,3-benzodiazepin-2-ones and 1,3-benzoxazepin-2-ones useful as hiv reverse transcriptase inhibitors
CO5180550A1 (es) * 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
FR2812635B1 (fr) * 2000-08-01 2002-10-11 Aventis Pharma Sa Nouveaux composes heterocycliques, preparation et utilisation comme medicaments notamment comme anti- bacteriens
FR2825705B1 (fr) * 2001-06-08 2005-05-20 Aventis Pharma Sa Nouveaux composes heterocycliques, leur preparation et leur utilisation comme medicaments, notamment comme anti-bacteriens
FR2835186B1 (fr) * 2002-01-28 2006-10-20 Aventis Pharma Sa Nouveaux composes heterocycliques, actifs comme inhibiteurs de beta-lactamases

Similar Documents

Publication Publication Date Title
JP2006512335A5 (https=)
JPH01113382A (ja) フェノール性チアン誘導体およびカラー写真記録材料の安定剤としてのそれらの使用方法
JP2002543183A5 (https=)
JP2020536881A5 (https=)
JP2010528089A5 (https=)
JP2002529532A5 (https=)
JP2004537541A5 (https=)
JP2007520471A5 (https=)
JP2005504789A5 (https=)
JP2005526076A5 (https=)
AR038536A1 (es) N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
JP2005510476A5 (https=)
JP2003503387A5 (https=)
JP2009515872A5 (https=)
WO2005113537B1 (en) Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
JP2005530709A5 (https=)
JP2006522035A5 (https=)
JP2005529956A5 (https=)
JP2005523310A5 (https=)
JP2008510828A5 (https=)
JP2019515643A5 (https=)
JP2006528621A5 (https=)
JP2006520397A5 (https=)
JP2003525286A5 (https=)
JP2005517643A5 (https=)